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Outgrowth Endothelial Progenitor Cells
Nana-Maria Heida, MD,* Jan-Peter Müller, MD,* I-Fen Cheng, MSC,* Maren Leifheit-Nestler, PHD,*
Vivien Faustin, PHD,† Joachim Riggert, MD,‡ Gerd Hasenfuss, MD,* Stavros Konstantinides, MD,*
Katrin Schäfer, MD*
Göttingen, Germany
Objectives The purpose of this study was to examine the impact of obesity and weight loss on the angiogenic and regenera-
tive capacity of endothelial progenitor cells (EPCs).
Background EPCs participate in angiogenesis and tissue repair. Several cardiovascular risk factors are associated with EPC
dysfunction.
Methods Early outgrowth EPCs were isolated from 49 obese (age 42  14 years; body mass index 42  7 kg/m2) normo-
glycemic participants in a professional weight reduction program and compared with those from 49 age-
matched lean controls. EPC function was tested both in vitro and in vivo.
Results EPCs expanded from the obese possessed reduced adhesive, migratory, and angiogenic capacity, and mice
treated with obese EPCs exhibited reduced EPC homing in ischemic hind limbs in vivo. EPCs from the obese sub-
jects failed to respond to conditioned medium of lean controls or to potent angiogenic factors such as vascular
endothelial growth factor. Although no differences existed between lean and obese EPCs regarding the surface
expression of vascular endothelial growth factor or chemokine receptors, basal p38 mitogen-activated protein
kinase (MAPK) phosphorylation was elevated in obese EPCs (3.7  2.1-fold increase; p  0.006). These cells
also showed reduced secretion of the angiogenic chemokines interleukin-8 (p  0.047) and monocyte chemoat-
tractant protein-1 (p  0.012). By inhibiting p38 MAPK, we could restore chemokine levels to those of lean con-
trol EPCs and also improve the angiogenic properties of obese EPCs. Accordingly, 6-month follow-up of 26 obese
persons who achieved significant weight reduction revealed normalization of p38 MAPK phosphorylation levels
and improved EPC function.
Conclusions Obesity is associated with a reversible functional impairment of EPCs. This involves reduced secretion of angio-
genic chemokines and increased basal phosphorylation of signaling molecules, notably p38 MAPK. (J Am Coll
Cardiol 2010;55:357–67) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.031l
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tlinical studies have identified a relationship between
ncreased body weight and cardiovascular disease including
oronary atherosclerosis, congestive heart failure, arrhyth-
ias, and stroke (1–3). In fact, obesity is frequently accom-
anied by a cluster of comorbidities and metabolic distur-
ances such as elevated blood pressure, dyslipidemia, and
nsulin resistance (4). However, in addition to these estab-
rom the Departments of *Cardiology and Pulmonology, †Nutritional Psychology,
nd ‡Transfusion Medicine, University of Göttingen, Göttingen, Germany. This
tudy was awarded the 2008 Hans Blömer Young Investigator Award for Clinical
ardiology by the German Cardiac Society to Dr. Heida. The study was supported
y a grant from the German Foundation for Heart Research (Deutsche Stiftung für
erzforschung) to Dr. Schäfer.p
Manuscript received April 23, 2009; revised manuscript received August 20, 2009,
ccepted September 1, 2009.ished cardiovascular risk factors, systemic inflammation,
ncreased oxidative stress, and altered hemodynamics asso-
iated with excess weight may directly contribute to endo-
helial injury and dysfunction and thus to the pathogenesis
f atherosclerosis in obese individuals (5).
Over the past decade, a role for endothelial progenitor
ells (EPCs) in cardiovascular homeostasis has emerged.
PCs are released from the bone marrow into the circula-
ion in response to cytokines and other stimuli signaling
issue injury (6). They can be isolated from the peripheral
lood and are characterized by the ability to differentiate
nto endothelium-like cells in culture (7). In particular, early
utgrowth EPCs may contribute to endothelial repair and
he neovascularization of ischemic tissue acting, at least in
art, as potent paracrine stimulators of angiogenesis (8–10).
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Obesity and Weight Loss January 26, 2010:357–67These cells are functionally dis-
tinct from leukocytes, although
they may share some surface
markers with the latter cell type
(7,11,12). A correlation between
circulating EPC numbers and
endothelial function has been
observed in patients with various
degrees of cardiovascular risk
13), and EPC numbers seemed to predict future cardio-
ascular events (14,15). Importantly, however, cardiovascu-
ar risk factors may also alter the functional capacity of EPCs.
or example, EPCs cultivated from persons with diabetes
xhibited impaired proliferation, adhesion, and integration
n vascular structures (16,17), suggesting that EPC dysfunc-
ion may participate in the vascular complications associated
ith this condition. We therefore hypothesized that obesity
ay also modulate the functional properties of circulating
PCs and in particular their potential to promote tissue
epair.
In the present study, we examined the adhesive, migra-
ory, and angiogenic capacity of early outgrowth EPCs
solated from the peripheral blood of 49 consecutive obese
body mass index [BMI] 35 kg/m2), nondiabetic individ-
als participating in a professional weight reduction pro-
ram and compared it with that of age-matched lean
olunteers. Obese persons were reexamined 6 months later,
nd the effects of weight loss on functional parameters of
heir EPCs were determined. Our findings reveal novel
otential mechanisms linking obesity to increased cardio-
ascular risk and also provide evidence supporting the
eneficial effects of weight loss.
ethods
tudy design and population. Peripheral venous blood
amples were collected in the morning from fasting obese
ndividuals attending a professional weight reduction pro-
ram (OPTIFAST-52, Nestlé Health Care Nutrition) at
he University of Göttingen. The program begins with a
2-week period of complete meal replacement by a formula-
ased, predominantly liquid diet. This is followed by a
-week transition to solid food and continues with a regular
iet, which is maintained thereafter. The program features
utritional and behavioral counseling; mild physical activity
1 h/week) is encouraged. Participants presenting with a
MI of 35 kg/m2 and fasting blood glucose levels 110
g/dl were included; we excluded smokers (100 cigarettes
uring lifetime) and persons with drug- or insulin-
ependent diabetes or known cardiovascular disease. Age-
nd sex-matched normal-weight (BMI 20 to 25 kg/m2)
ealthy volunteers were recruited as controls. Six months
ater, study participants were again examined for follow-up
nalysis of EPC function if sufficient weight reduction
defined as current BMI 35 kg/m2 and/or 10% loss of
Abbreviations
and Acronyms
BMI  body mass index
EPC  endothelial
progenitor cell
MAPK  mitogen-activated
protein kinaseody weight compared with baseline) had been achieved. she study protocol was approved by the institutional ethics
ommittee, and written informed consent was obtained
rom all study participants.
lasma parameters. Plasma lipid profile was determined
nzymatically (MODULAR P/D, Roche Diagnostics, Mann-
eim, Germany). Plasma high-sensitivity C-reactive protein
as measured using turbidimetry after agglutination with
ntibody-coated latex particles (COBAS INTEGRA 800,
oche Diagnostics). Plasma asymmetrical dimethylarginine
DLD Diagnostika, Hamburg, Germany), E-selectin (Ray-
iotech, Inc., Norcross, Georgia; Hölzel Diagnostika, Köln,
ermany), interleukin-6 (RayBiotech), leptin (R&D Systems,
inneapolis, Minnesota), and tumor necrosis factor- (R&D
ystems) levels were determined using specific immunoassays.
solation, cultivation, and characterization of EPCs. Mono-
uclear cells were isolated from venous blood by density-
radient centrifugation over Histopaque-1077 (Sigma-
ldrich, St. Louis, Missouri) as described (8). On day 7,
ultivated cells were characterized based on the uptake of
cetylated low-density lipoprotein and binding of Ulex
uropaeus agglutinin-I (lectin) as well as endothelial cell
arker expression (8). Overall, 70  17% of the cells were
ositive for CD31, 68 12% for CD144, and 89 11% for
ascular endothelial growth factor receptor 2. Based on the
solation and cultivation protocol, the adherent mononu-
lear cells were identified as early outgrowth EPCs (7).
Analysis of EPC adhesion, migration, and angiogenesis;
ow cytometry; and Western blot and assessment of cyto-
ine secretion into the conditioned medium of EPCs are
escribed in the Online Supplemental Methods.
tatistical analysis. For quantitative data, results are pre-
ented as mean  SD (except for the figures, where they
ppear as mean  SEM), and for qualitative data, they are
resented as absolute numbers and relative frequencies. The
odified D’Agostino and Pearson test was used to test for
ormal distribution of continuous variables, and the paired
test was used for comparison of values between obese
ndividuals and matched lean controls (except for the hind
imb ischemia experiments, in which the unpaired t test was
sed). For comparison of obese individuals after weight loss
ith values at baseline and matched lean controls, repeated-
easures analysis of variance was performed followed by the
onferroni test. For comparison of categorical parameters,
he McNemar test was used. A p value 0.05 was consid-
red statistically significant. Statistical analysis was per-
ormed using GraphPad Prism software 4.01 (GraphPad
oftware, Inc., La Jolla, California).
esults
aseline parameters of obese and lean subjects. EPCs
ere cultivated from the mononuclear cell fraction of 49
everely obese individuals (31 women), age 42  14 years at
he time of enrollment; the control group consisted of 49
ean healthy volunteers (28 women), age 38  11 years. As
hown in Table 1, obese persons exhibited elevated high-
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January 26, 2010:357–67 Obesity and Weight Lossensitivity C-reactive protein (p  0.001) and leptin (p 
.001) concentrations compared with their lean counter-
arts. Conversely, plasma levels of interleukin-6, tumor
ecrosis factor-, or markers of endothelial dysfunction
uch as E-selectin, asymmetrical dimethylarginine, and the
umber of circulating endothelial cells did not differ be-
ween the 2 groups.
PCs from obese persons are functionally impaired. Fewer
cetylated low-density lipoprotein, lectin-double positive
PCs could be cultivated from the obese subjects compared
ith lean controls (70 22% vs. 100 26%; p 0.006; 10
ubjects per group). Of note, we detected no differences in
he degree of EPC proliferation as assessed by immunohis-
ochemical analysis of bromodeoxyuridine incorporation
1% positive cells in either group) or in apoptosis rate as
ssessed by flow cytometry for annexin V binding in
onjunction with the vital dye propidium iodide (not
hown). Conversely, our experiments revealed impaired
dhesion of EPCs from obese persons to fibronectin com-
ared with lean controls (p  0.018; 8 per group). Repre-
entative findings are shown in Figure 1A (left vs. middle)
cumulative results shown in Fig. 1D, left). Similar differ-
nces were observed regarding the adhesion of EPCs to
itronectin (11  5.8 vs. 36  11; p  0.001; not shown).
oreover, EPCs from the obese subjects were characterized
y reduced migratory capacity (p  0.001; 8 per group)
Fig. 1B, left vs. middle) (cumulative results shown in Fig. 1D,
iddle). In further experiments using the Matrigel angio-
enesis assay, EPCs from the obese subjects exhibited an
mpaired ability to incorporate into network-like structures
rovided by cocultivated human umbilical vein endothelial
ells (p  0.001; 7 per group) (Fig. 1C) (cumulative results
Clinical and Laboratory Parameters of 49 ObeseTable 1 Clinical and Laboratory Parameters
Body weight (kg)
Body mass index (kg/m2)
Waist circumference (cm)
Hypertension
Fasting glucose (mg/dl)
Triglycerides (mg/dl)
Low-density lipoprotein cholesterol (mg/dl)
High-density lipoprotein cholesterol (mg/dl)
High-sensitivity C-reactive protein (mg/l)
Leptin (ng/ml)
Tumor necrosis factor- (pg/ml)
Interleukin-6 (pg/ml)
E-selectin (ng/ml)
Asymmetrical dimethylarginine (mol/l)
Circulating endothelial cells/ml
Angiotensin-converting enzyme inhibitors
Angiotensin II receptor subtype 1 (AT1) blockers
Statins
Values are mean  SD or n (%). p values in bold indicate significant
p values were determined by Student t test for paired means.
n.d.  not determined.hown in Fig. 1D, right). sNext, we analyzed the effects of obesity on the angiogenic
apacity of EPCs in vivo. Chloromethylbenzamido-DiI (a
arbocyanine dye)–labeled EPCs from obese subjects were
ess frequently detected within the ischemic hind limb
usculature 10 days after injection into nude mice (28 25
s. 88  85 chloromethylbenzamido-DiI–positive cells/
m2; p  0.017; 11 mice per group) (Fig. 2A). Moreover,
ice treated with EPCs from obese subjects revealed a
educed angiogenic response assessed by the number of
D31-positive cells per square millimeter (p  0.036 vs.
ean) (Fig. 2B).
ltered paracrine potency of EPCs in obesity. To inves-
igate whether alterations of the secretion profile may
ontribute to the impaired adhesive, migratory, and angio-
enic properties of EPCs in obesity, crossover experiments
sing conditioned medium from either lean or obese EPCs
ere performed. The Matrigel angiogenesis assay after a 24
our-incubation of obese EPCs with homologous (i.e.,
erived from obese EPCs) conditioned medium confirmed
he reduction of their incorporation into endothelial net-
orks compared with lean EPCs incubated with homolo-
ous (from lean EPCs) conditioned medium (p  0.009)
first column vs. third column in Fig. 3A). Interestingly,
reincubation with heterologous conditioned medium
from obese EPCs) reduced the angiogenic capacity of lean
PCs (p  0.003 vs. lean EPCs with homologous condi-
ioned medium; n  9) (first column vs. second column in
ig. 3A), indicating a disturbed secretion of angiogenic
ediators in EPCs from obese individuals. Further analysis
f the paracrine potency of EPCs derived from obese as
pposed to lean individuals supported these results: these
iduals and 49 Lean ControlsObese Individuals and 49 Lean Controls
Obese Lean p Value
5 24 69 11 <0.001
2 7 22 2.2 <0.001
1 17 n.d. —
6 (33) 6 (12) 0.009
4 9.2 n.d. —
7 90 148 82 0.144
5 29 112 30 0.136
8 12 54 10 0.005
7 5 1.2 1.7 <0.001
9 35 4.1 3.1 <0.001
3 1.8 5.3 3 0.499
4 20 11 9.8 0.100
0 2.8 4.0 1.6 0.367
4 0.03 0.26 0.09 0.373
0 1.4 11 1.5 0.695
3 (27) 0 <0.001
3 (6) 0 0.248
9 (18) 0 0.008
ces. Except for hypertension and medication (categorical variables),Indivof 49
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o enhance migration of mature human umbilical vein
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Figure 1 Effects of Obesity and Weight Loss on Functional Pro
Chloromethylbenzamido-DiI–labeled endothelial progenitor cell (EPC) (red; 4,6-diam
peripheral blood of lean or obese individuals, were analyzed for their capacity to a
rate into network-like structures provided by human umbilical vein endothelial cells
some obese individuals, the studies were repeated after weight loss. (D) Cumulat
###p  0.001 versus obese.ndothelial cells in the modified Boyden chamber assay ip  0.026; 4 per group; not shown) or to stimulate
prouting of mature human umbilical vein endothelial cells
weight loss
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henylindole–positive cell nuclei appear blue in A and B), isolated from the
to fibronectin (A), migrate in the modified Boyden chamber assay (B), or incorpo-
lucent cells) in the Matrigel angiogenesis assay (C; arrows point to EPCs). In
ults. *p  0.05 and ***p  0.001 versus lean; #p  0.05, ##p  0.01, andobe
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January 26, 2010:357–67 Obesity and Weight LossTo characterize the secretion profile of EPCs from obese
ompared with lean individuals, conditioned medium of
ells was examined using cytokine antibody arrays. Semi-
uantitative analysis (3 independent experiments of pooled
Figure 2 Effects of Obesity on the Angiogenic Properties of EP
After induction of hind limb ischemia and injection of chloromethylbenzamido-DiI (C
5-m-thick serial cryosections were analyzed for the presence of EPCs (red signal
(blue signal) demonstrates that no artificial signals were counted (A, bottom). (B
square millimeter (green signal; 4,6-diamino-2-phenylindole–positive cell nuclei ap
(left) lower hind limb. *p  0.05 and #p  0.05 versus lean; **p  0.01 versusonditioned medium from 4 subjects per group) revealed 0ifferentially expressed levels of interleukin-8 and monocyte
hemoattractant protein-1. Subsequent quantitative analysis
y enzyme-linked immunosorbent assay confirmed a signif-
cant reduction of the angiogenic factors interleukin-8 (p 
Vivo
–labeled endothelial progenitor cells (EPCs) from either lean or obese subjects,
s in A, top); costaining of cell nuclei with 4,6-diamino-2-phenylindole (DAPI)
sess angiogenesis after ischemia, the density of CD31-positive capillaries per
lue) was determined in the ischemic (right) and the contralateral nonischemic
chemic leg.Cs In
M-DiI)
; arrow
) To as
pear b
nonis.047; 12 per group) and monocyte chemoattractant protein
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Figure 3 Paracrine Effects and Secretion Profile of EPCs From Obese Versus Lean Individuals
(A) Conditioned medium was harvested, and its effects on the angiogenic properties of EPCs were tested using the Matrigel assay. (B) The effect of conditioned
medium alone on the sprouting of human umbilical vein endothelial cells was analyzed using the spheroid angiogenesis assay. (C) Cytokines in conditioned medium
from lean versus obese individuals, before and after weight loss: representative findings of cytokine antibody arrays (3 independent experiments, each using conditioned
medium pooled from 4 persons per study group; interleukin (IL)-6 and tumor necrosis factor (TNF)- were not detected by the assay) together with the corresponding
quantitative analysis using specific enzyme-linked immunosorbent assays. *p  0.05 and **p  0.01 versus lean. CdM  conditioned medium; HUVEC  human umbil-
ical vein endothelial cell; MCP  monocyte chemoattractant protein; WL  weight loss; other abbreviation as in Figure 2.
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January 26, 2010:357–67 Obesity and Weight Loss(p  0.012; n  7) concentrations in the conditioned
edium from obese compared with that from lean EPCs
Fig. 3C). Conversely, we detected similar levels of
nterleukin-6 (p  0.345; 10 per group), stromal cell-
erived factor-1 (p  0.793; n  16; not shown), and
umor necrosis factor- (p  0.795; n  7), whereas
ascular endothelial growth factor levels were below the
etection limit (5 pg/ml).
ossible signaling defects of EPCs in obesity. Apart
rom alterations of the secretion profile of EPCs in obesity,
ur crossover experiments also showed that the impaired
ncorporation of obese EPCs into endothelial structures
ould not be rescued by the addition of conditioned medium
rom lean EPCs (p  0.614 versus the addition of obese
onditioned medium to obese EPCs; 9 per group) (third
olumn vs. fourth column in Fig. 3A). This finding indi-
ated that obese EPCs also exhibited an impaired response
o factor(s) present in conditioned medium from lean EPCs.
o begin to clarify this finding, we compared the respon-
iveness of lean and obese EPCs to stimulation with a
otent angiogenic growth factor such as vascular endothelial
rowth factor. These experiments revealed a reduced angio-
enic response of obese EPCs to vascular endothelial
rowth factor in the Matrigel assay compared with lean
PCs (p  0.012 after stimulation with 10 ng/ml; 6 per
roup [Fig. 4A] and p 0.017 with 100 ng/ml; not shown).
imilar results were obtained using the spheroid angiogen-
sis assay (p  0.003 after stimulation with 10 ng/ml
ascular endothelial growth factor, 6 per group [Fig. 4B]
nd p  0.018 with 100 ng/ml; not shown).
In light of these results, we first analyzed the expression
f the 2 major vascular endothelial growth factor receptors
n EPCs (Fig. 4C). However, flow cytometry revealed no
ifferences between EPCs from obese individuals (n  12)
nd lean controls (n 12) regarding the expression of either
ascular endothelial growth factor receptor 1 (receptor-
ositive EPCs, 62  13% vs. 65  9.2%; p  0.813) or
ascular endothelial growth factor receptor 2 (94 6.5% vs.
9  9.4%; p  0.053). Moreover, expression of the
ounterreceptors for monocyte chemoattractant protein-1
chemokine [C-C motif] receptor 2) and interleukin-8
chemokine [C-X-C motif] receptor 2) also did not differ
ignificantly between lean and obese EPCs (Fig. 4C).
In contrast to the unaltered expression of specific recep-
ors on EPCs in obesity, when intracellular signaling mol-
cules were investigated by Western blot analysis, signifi-
antly higher baseline p38 MAPK phosphorylation levels
3.7  2.1-fold) were found in EPCs from obese compared
ith lean individuals (p  0.006) (representative blot in
ig. 5A) (summarized results from 9 persons per group in
ig. 5B). These results suggested that increased phosphor-
lation of signaling molecules and modulation of post-
eceptor signal transduction pathways may contribute to the
educed angiogenic capacity of EPCs in obesity. In support
f this notion, we could also show that inhibition of p38
APK (using 20 M of SB203580) significantly increasedVEGFR1 VEGFR2
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Figure 4 Response of EPCs From Lean and
Obese Persons to Angiogenic Factors
The angiogenic response of EPCs to stimulation with vascular endothelial growth
factor (VEGF) (10 ng/ml for 24 h) was analyzed using the Matrigel (A) and the
spheroid (B) angiogenesis assays. Results are expressed as percentage of
unstimulated cells. (C), Expression of the indicated surface receptors was ana-
lyzed using flow cytometry: representative histograms (green line, lean EPCs; red
line, obese EPCs; gray line, IgG control). *p  0.05 and **p  0.01 versus
unstimulated cells; #p  0.05 and ##p  0.01 versus stimulated cells from lean
individuals; §§p  0.01 versus stimulated cells from obese individuals. CCR2 
chemokine (C-C motif) receptor 2; CXCR2  chemokine (C-C motif) receptor 2;
PE  phycoerythrin; VEGFR  vascular endothelial growth factor receptor; other
abbreviations as in Figures 1 and 3.
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Obesity and Weight Loss January 26, 2010:357–67nterleukin-8 (p  0.04) and monocyte chemoattractant
rotein-1 (p  0.02) levels in the conditioned medium of
bese EPCs, resulting in levels similar to those found in
onditioned medium from lean EPCs (Fig. 5C). Moreover,
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Figure 5 Effects of Weight Loss and p38 MAPK Inhibition on B
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January 26, 2010:357–67 Obesity and Weight Lossan be reversed by weight loss, we reexamined 6 months
ater 26 obese participants (12 men, 14 women) in the
rogram who successfully reduced their weight (as defined
n the Methods section). The clinical and laboratory param-
ters of this subgroup at baseline and follow-up are shown
n Table 2. Of note, the baseline medication of the obese
ubjects (Table 1) remained unchanged during this period.
eight loss seemed to restore the number of acetylated
ow-density lipoprotein, lectin double-positive cells (p 
.05 vs. initially obese and p 0.05 vs. lean controls; 10 per
roup; not shown). Furthermore, weight loss improved the
dhesive properties of EPCs from obese persons on matrix
roteins and particularly on fibronectin (p  0.05 vs.
nitially obese and p  0.05 vs. lean; 5 per group) (Fig. 1A,
ight) (cumulative results shown in Fig. 1D, left) and
itronectin (p  0.01 and p  0.05, respectively; not
hown). The intervention also normalized the migratory
ctivity of EPCs in vitro (p  0.001 vs. initially obese and
 0.05 vs. lean; 8 per group) (Fig. 1B, right) (cumulative
esults shown in Fig. 1D, middle), and restored their
ngiogenic properties in the Matrigel assay (p  0.01 and
 0.05, respectively; n  7) (Fig. 1C, right) (cumulative
esults shown in Fig. 1D, right).
In further experiments, weight loss normalized the respon-
iveness of EPCs to vascular endothelial growth factor, both in
he Matrigel (p  0.008 vs. unstimulated cells, p  0.01 vs.
timulated obese EPCs, and p 0.05 vs. lean EPCs) (Fig. 4A)
nd in the spheroid angiogenesis assay (p 0.076 vs. unstimu-
ated cells and p 0.05 vs. lean EPCs) (Fig. 4B). Importantly,
he restored responsiveness of EPCs after weight loss was
ssociated with a reduction of basal tyrosine phosphorylation of
38 MAPK-activated protein kinase (from 3.7  2.1-fold to
.1  1.1-fold compared with baseline; p  0.001 and p 
.05 vs. lean controls) (Fig. 5A) (summarized results in 9
ersons shown in Fig. 5B). Conversely, analysis of conditioned
edium revealed that weight loss did not alter the secretion of
nterleukin-8 or monocyte chemoattractant protein 1 of EPCs
Clinical and Laboratory Parameters of 26 ObeseIndividuals Before and After Successful WeightTable 2 Clinic l and Laboratory Paramet rsIndividuals Before and After Succes
At
Body weight (kg) 13
Body mass index (kg/m2) 4
Waist circumference (cm) 13
Hypertension 1
Fasting glucose (mg/dl) 9
Triglycerides (mg/dl) 14
Low-density lipoprotein cholesterol (mg/dl) 12
High-density lipoprotein cholesterol (mg/dl) 4
High-sensitivity C-reactive protein (mg/l) 5
Leptin (ng/ml) 4
Interleukin-6 (pg/ml) 2
Values are mean  SD or n (%). p values in bold indicate significan
determined by paired t test.rom obese individuals at 6-month follow-up (Fig. 3C). ciscussion
he importance of obesity as a contributor to cardiovascular
orbidity and mortality is rapidly increasing worldwide. In
he present study, we examined whether the adverse cardio-
ascular effects of excess body weight may be mediated, at
east in part, by a decreased capacity of EPCs to promote
ndothelial repair and neovascularization. The main find-
ngs of our study can be summarized as follows. 1) EPCs
rom obese subjects were characterized by reduced adhesive,
igratory, and angiogenic capacities and were less capable
f promoting angiogenesis after induction of hind limb
schemia in vivo in a mouse model. 2) These findings were
ssociated with alterations in the secretion profile of EPCs
nd with intracellular signaling defects and reduced respon-
iveness to angiogenic stimuli. 3) The functional deficiency
f cultivatable EPCs could be reversed after significant
eight reduction.
Reduced numbers of circulating EPC have been reported
n persons with cardiovascular risk factors, and EPC levels
ere found to inversely correlate with waist circumference
nd BMI (18). Experimental evidence suggests beneficial
ffects of lifestyle modification including exercise (19) and
moking cessation (20) on EPC numbers, and recently a
ignificant increase in the number of circulating CD34,
D117 double-positive cells was reported after weight loss
n obese subjects (18). However, the ability of EPCs to
onfer vascular protection depends not only on their abso-
ute numbers or concentrations, but also on their functional
roperties. Using 2 different in vitro assays, we could show
hat EPCs cultivated from obese subjects were characterized
y reduced adhesive and migratory capacity compared with
PCs from lean controls and exhibited an impaired ability
o incorporate into network-like structures provided by
ocultivated mature endothelial cells. Importantly, these
efects of EPCs were reversible after significant weight loss.
f note, early outgrowth EPCs are characterized by a low
roliferative potential, which is in contrast to endothelial
Obese
eight Loss
ne At 6-Month Follow-Up p Value
8 108 20 <0.001
.5 35 5.7 <0.001
6 115 15 <0.001
10 (38) 0.480
.9 91 8.4 0.063
6 114 47 0.004
5 115 33 0.024
.7 57 31 0.106
.9 3.8 3.8 0.300
3 21 20 0.001
1 19 11 0.676
ences. Except for hypertension (categorical variable), p values wereLossof 26
sful W
Baseli
4 2
3 8
1 1
2 (46)
6 9
9 5
6 2
6 9
.0 3
9 3
4 2olony-forming cells (7,21), and we detected no differences
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ean and obese individuals.
The ability to home, adhere, and incorporate into vascular
tructures is a prerequisite for functional competence of
PC and represents an important feature underlying their
asoregenerative potential. In this regard, animal models of
iabetes have pointed to an impaired potency of progenitor
ells for therapeutic angiogenesis (22–24). The findings of
he present study, as obtained in the in vivo mouse model of
ind limb ischemia, now suggest that obesity itself (i.e.,
eyond the contribution of diabetes or insulin resistance)
ay impair the potential of early outgrowth human EPCs
o incorporate into vascular structures and promote angio-
enesis. In this regard, we excluded from the present study
bese individuals who had a fasting plasma glucose level
110 mg/dl (in accordance with existing criteria for the
efinition of impaired fasting glucose [4]), as well as those
ith known diabetes mellitus. Thus, although we cannot
ompletely exclude the possibility that some of the obese
PC donors may have had impaired glucose tolerance, it is
nlikely that insulin resistance significantly contributed to
ur findings. Moreover, we detected no differences between
bese individuals and lean controls with regard to plasma
-selectin or asymmetrical dimethylarginine levels or the
umber of circulating endothelial (CD146, CD31 double-
ositive) cells. These latter findings support the notion that
he functional impairment of the EPCs isolated from obese
ubjects was independent of the presence of generalized
ndothelial dysfunction.
After the homing process, EPCs become capable of
ecreting angiogenic growth factors, which may stimulate
asculogenesis in a paracrine fashion (9). In our experi-
ents, conditioned medium of early outgrowth EPCs
timulated the migration and sprouting of mature endo-
helial cells. Notably, however, the angiogenic potential
f conditioned medium of EPCs cultivated from obese
ubjects was markedly reduced, and analysis of the super-
atant revealed significantly reduced levels of the pro-
ngiogenic cytokines interleukin-8 and monocyte chemoat-
ractant protein-1.
Beyond alterations of the secretion profile we found that,
sing both the Matrigel and the spheroid angiogenesis
ssay, EPCs from obese individuals were themselves less
apable of responding to conditioned medium from healthy,
ean EPCs or to potent angiogenic growth factors such as
ascular endothelial growth factor. Flow cytometry showed
o abnormalities in vascular endothelial growth factor
eceptor surface expression and also no general defect in the
xpression of important chemokine receptors, including
hose for interleukin-8 and monocyte chemoattractant
rotein-1, on obese EPCs. However, we did observe altered
ntracellular signal transduction and particularly increased
asal phosphorylation of p38 MAPK. Vascular endothelial
rowth factor-induced endothelial cell migration seems to
equire p38 activation (25), and it remains to be clarified pow increased basal phosphorylation of the kinase in obesity
ay impair growth factor signaling. In any case, the
athophysiological relevance of the p38 activation status is
upported by our further experiments, which showed that:
) the p38 increased basal phosphorylation detected in obese
ndividuals was reversible on weight loss; and 2) p38 MAPK
nhibition restored both the levels of the angiogenic cyto-
ines interleukin-8 and monocyte chemoattractant protein-1
n the conditioned medium, and the angiogenic properties of
bese EPCs to those of lean controls.
Because p38 MAPK-dependent pathways operate down-
tream of several cytokine and growth factor receptors, the
nhanced p38 MAPK phosphorylation levels in obesity may
e the result of long-term exposure to elevated levels of the
umerous pro-inflammatory mediators in this condition (5).
earching for possible candidates, we found elevated circu-
ating levels of leptin and C-reactive protein in the obese.
ndeed, exposure of endothelial (and other) cells to
-reactive protein has been shown to lead to rapid p38
APK, and inhibition of p38 MAPK may prevent a
-reactive protein-induced pro-inflammatory phenotype
nd endothelial dysfunction (26 –28). Tumor necrosis
actor- and high glucose levels also have been shown to
nduce p38 MAPK phosphorylation in EPCs (29); in the
resent study, however, plasma glucose levels of obese
ndividuals were within the normal range, and we found no
ifferences in tumor necrosis factor- concentrations in
ither the plasma or the EPC conditioned medium of obese
ersus lean study participants.
Although the obese individuals included in our study had
ower high-density lipoprotein cholesterol levels and a
igher incidence of arterial hypertension than lean controls,
hese risk factors were not significantly affected by weight
eduction. Moreover, it is unlikely (even though it cannot be
ompletely excluded) that the beneficial effects of weight
eduction were partly attributable to increased physical
xercise because this particular program includes only mild
hysical activity (1 h/week), which is far below current
ecommendations (30).
onclusions
ur findings demonstrate impaired adhesive, migratory,
nd angiogenic properties of EPCs isolated from the mono-
uclear cell fraction of obese individuals. These in vitro and
n vivo results suggest that defects in EPC-mediated endo-
helial repair may be involved in the pathogenesis of
besity-associated cardiovascular disease. Although the
hort duration of follow-up did not allow us to directly
ssess the impact of EPC (dys)function on the cardiovas-
ular morbidity and mortality of the subjects studied, our
ndings strongly support the importance of lifestyle modi-
cation and particularly weight reduction in the primary
revention of cardiovascular disease.
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